DarioHealth Corp. (DRIO) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 8 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for DRIO is $16.00, representing a +111.6% upside from the current price of $7.56. Price targets range from a low of $16.00 to a high of $16.00.
